CD Bioparticles Launches Custom Latex Immunoturbidimetric Assay (LIA) Development Services to Accelerate IVD Innovation
Sep 22, 2026
CD Bioparticles launches end-to-end Custom Latex Immunoturbidimetric Assay development services for research applications.
New York, NY, United States, September 22, 2026 /MarketersMEDIA/ -- With years of experience in the pharmaceutical and life science sectors, CD Bioparticles has announced the expansion of its diagnostic capabilities with the launch of its end-to-end Custom Latex Immunoturbidimetric Assay development services. These services offer full-spectrum assay customization ranging from particle conjugation to fully optimized kit assembly, and can help researchers and diagnostic developers to streamline IVD reagent manufacturing and clinical biomarker quantification.
The immunoturbidimetry method is an analytical technique combining liquid-phase precipitation reactions with optical instruments and automated analysis. However, due to issues relating to the size and quantity of antigen-antibody complexes, the immunoturbidimetry has low sensitivity and a narrow detection range. This has led to the development of the latex immunoturbidimetric assay (LIA). This technique uses latex microparticles that are coated with specific antibodies or antigens.
When these particles encounter the target analyte in a sample, they form specific aggregates through antigen-antibody interactions. The aggregation of these particles increases the scattering intensity or absorbance of the latex suspension. This increase is quantitatively correlated with the concentration of the target analyte in the sample. Turbidity measurements are performed using a biochemical analyser, and the entire analytical process takes only a few minutes. Compared to traditional immunoturbidimetric methods, this method offers significantly higher sensitivity, with detection limits as low as ng/mL or pg/mL.
CD Bioparticles has extensive experience in assay solutions and now offers custom services to help researchers and diagnostic product developers develop latex immunoturbidimetric assays. The company's service portfolio ranges from custom conjugation to the optimization of complete immunoturbidimetric assays. The company provides custom-made, carboxyl-functionalized polystyrene microspheres that are conjugated with antigens or antibodies and come in various sizes. CD Bioparticles also offers complete kits for the quantitative detection of a wide range of biomarkers. These products feature high sensitivity, short assay times and compatibility with automated biochemical analyzers.
CD Bioparticles offers customers carboxyl-modified polystyrene microparticles in a range of sizes (from 0.07 to 0.4 μm) that are suitable for developing latex immunoturbidimetric assay reagents. CD Bioparticles' standard products feature a moderate surface carboxyl density; products with higher or lower densities are also available upon request. Additionally, CD Bioparticles can customize the conjugation of antibodies and antigens to meet specific application requirements. Through optimization, the team can ensure high conjugation efficiency while maintaining the activity of both antibodies and antigens.
CD Bioparticles also offers reagent formulation development and optimization services to help customers improve reagent stability, optimize reaction conditions and enhance detection sensitivity. The company offers performance validation services to verify key performance indicators, including linearity, sensitivity, specificity and precision, ensuring stability across different batches and under various operating conditions.
For more information about CD Bioparticles' Custom Latex Immunoturbidimetric Assay development services or to submit a project inquiry, please visit https://www.cd-bioparticles.com/services/latex-immunoturbidimetric-assay-development.html.
About CD Bioparticles
CD Bioparticles is a leading manufacturer and supplier of various nanoparticles, microparticles, and coatings for R&D as well as commercialization across different application areas, including in vitro diagnostics, biochemistry, cellular analysis, cell separation, and immunoassay. The company also offers various custom services, including chemical surface-functionalization, fluorescent modification, antibody immobilization, as well as nucleic acid and oligo conjugation to meet client specifications.
Contact Info:
Name: Richard J. Gray
Email: Send Email
Organization: CD Bioparticles
Website: https://www.cd-bioparticles.com/
Release ID: 89204007
If you encounter any issues, discrepancies, or concerns regarding the content provided in this press release that require attention or if there is a need for a press release takedown, we kindly request that you notify us without delay at [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our responsive team will be available round-the-clock to address your concerns within 8 hours and take necessary actions to rectify any identified issues or guide you through the removal process. Ensuring accurate and reliable information is fundamental to our mission.
More News
Malicious npm Package Poses as Twilio Bug-Bounty Probe, Can Exfiltrate Credentials
Cybersecurity researchers have disclosed details of a malicious npm package named "tw-pkgprobe-7731" that masquerades as a security tool targeting developers integrating Twilio into their applications, while stealthily attempting to harvest sensitive data. The package, named "tw-pkgprobe-7731," was first uploaded to the npm registry in mid-August 2026 by an npm account named "twdepprobe7731."
Microsoft Takes Down EvilTokens Device-Code Phishing Service Tied to 12,000 Inbox Compromises
Microsoft on Tuesday announced the takedown of the EvilTokens device code phishing service that it said used artificial intelligence (AI) "at every step of the attack chain." The action, carried out with authorization from the U.S. District Court for the Eastern District of Virginia, involved the efforts of Health-ISAC, alongside Cloudflare, Coinbase, OpenAI, Railway, SpyCloud, The Shadowserver
Critical Bifrost AI Gateway Flaw Lets Attackers Run Commands Without Credentials
A critical vulnerability in Bifrost, an open-source AI gateway that routes requests to more than 20 LLM providers, allows an unauthenticated attacker to run arbitrary commands on the gateway server with a single HTTP request. The flaw, tracked as CVE-2026-90898 (CVSS score: 9.8), affects all versions of the Bifrost HTTP transport before 2.1.0 when management authentication is
The Big Threat Has Been Climate Change. Now Comes A.I.
Both are human-caused, both are frightening, and one of them has raced to the forefront of the global conversation.
Sea turtle laying eggs at Huntington Beach is first known instance of nesting on West Coast
At least one olive ridley sea turtle has laid its eggs on the sand in Huntington Beach.
Researcher Drops BigDiskBuster Zero-Day PoC That Blocks Microsoft Defender Updates
A zero-day proof-of-concept tool that stops Microsoft Defender from installing platform and signature updates by filling all available disk space was published on GitHub on September 19. The tool, called BigDiskBuster, has no patch, no CVE, and no Microsoft advisory. Its author, Abdelhamid Naceri, is a former Microsoft security researcher whose earlier Defender exploits were used in
C.T.E. Can’t Be Detected in the Living. New Brain Research Offers Hope.
Scientists are developing imaging techniques and blood tests that one day may enable doctors to identify the disease definitively in living patients.
Mathematics Isn’t Just a Game to Let A.I. Solve. History Shows Why.
In our field of applied mathematics, the long, human process of trial and error — not just the solutions themselves — is often what has led to progress.
Man vs robot: Influencer takes on 6ft humanoid in a terrifying cage fight - and it doesn't end well for him
It might sound like the plot of a bonkers sci-fi film, but the world has now witnessed the very first human vs robot boxing match.
Gen Z are in a sex RECESSION, study reveals - with a fifth reporting they've never had a partner
Despite being the generation that grew up with Tinder, Hinge and Bumble at their fingertips, a study has revealed Gen Z is in a sex recession.
Call of Duty's Activision to make next Halo game as Xbox cuts more jobs
The news comes as part of a "reset" announced by Xbox in July, with 3,600 planned job losses overall.
China’s Hygon moves beyond data centres with embedded processors for robotics, edge AI
Chinese chipmaker Hygon Information Technology on Tuesday launched a suite of central processing units (CPUs) for robotics and industrial edge devices, expanding beyond cloud computing and into the fast-growing market for physical artificial intelligence. The firm unveiled its Hygon 1000 series processors, designed to be embedded into physical devices in industrial automation systems such as robotics and factory controllers, enabling computing and graphics processing to be handled locally. Built...
Recommended
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.